Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Agricultureread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
A quarter of the S&P 500 companies report earnings next week, and that could buffet the market as investors await the July Fed meeting.Market Insiderread more
Iran's Revolutionary Guard claims a British tanker it still holds, Stena Impero, failed to follow international maritime rules.World Newsread more
Moving lots of data to a public cloud over the internet can take months or years. CNBC got an inside look at how AWS transfers data to the cloud for its clients.Technologyread more
The president also said he "offered to personally vouch" for Rocky's bail. Sweden, however, does not have a bail system.Politicsread more
CoinShares Chief Strategy Officer Meltem Demirors discusses Facebook's Libra project and its impact on the cryptocurrency market after testifying to the House Financial...Fast Moneyread more
Some 40% of Americans would struggle to come up with even $400 to pay for an emergency expense. Just how are so many Americans so short on cash? Blame debt.Personal Financeread more
Amazon hires Trump-allied lobbyist Jeff Miller as battle for Pentagon contract heats up.Politicsread more
In a series of tweets, the president addressed an unusual controversy stemming from a speech delivered Thursday by New York Fed President John Williams.Marketsread more
The Trump administration has withdrawn its proposal to eliminate rebates from government drug plans, a key component of the president's blueprint to lower prescription drug prices, a White House spokesman confirmed.
"Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule," White House spokesman Judd Deere said in an emailed statement Thursday.
The administration sought to ban discounts on prescription drugs that insurers negotiate with pharmaceutical companies, saying these "backdoor rebates" have led to a "perverse incentive" for drugmakers to set list prices on drugs artificially high. Instead, the rule would give pharmacy benefit managers a flat fee for including drugs on their plan and would allow discounts to be passed on to patients at the pharmacy counter.
Health and Human Services Secretary Alex Azar touted the plan as a way to "bring real transparency to drug markets and deliver savings directly to patients when they walk into the pharmacy." However, the Congressional Budget Office found the rule would cost $177 billion through 2029.
Insurers opposed the proposal, saying it would not accomplish its goal of lowering prescription drug prices.
CVS in a statement said it is "pleased" with the administration's move and that "any solution should start with addressing drug prices."
Axios reported the news earlier.
Deere said the Trump administration is "encouraged by continuing bipartisan conversations about legislation" to lower prescription drug costs and the president "will consider using any and all tools" to ensure drug prices decline.
— CNBC's Bertha Coombs contributed to this report.